Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease

White leghorn chickens on five farms were given a bivalent Marek's disease (MD) vaccine consisting of turkey herpesvirus (HVT) and SB-1 (a nononcogenic MD virus); other chickens received only HVT. The farms had histories of "vaccination failures," presumably owing to an exceptionally virulent challenge MD virus. The bivalent vaccine uniformly protected chickens better than HVT alone between 12 and 16-20 weeks of age, when serious MD losses occurred. During that period, total mortality in groups given both viruses ranged from 0.39 to 1.26% (mean 0.86%), whereas that in HVT-vaccinated groups not exposed to SB-1 varied from 1.92 to 7.44% (mean 3.43%). Chickens in pens or rows with close contact to those given bivalent vaccine also had low MD mortality rates (0.46-1.06%, mean 0.77%), probably from the spread of SB-1.     

A note on the structure and iron‐binding properties of egg‐shell membranes

1. When a solution of ferric ammonium sulphate was added to shell membranes of the domestic fowl, iron infiltrated the mantle (cortex) surrounding the cores of the individual fibres of the membranes.

2. Contraction of warm eggs in ice‐cold colloidal iron caused flooding of pore canals and contamination of the underlying shell membranes with this element.

3. Appreciable contamination of the inner shell membrane with iron persisted for 25 d in infertile eggs stored at 37.5 °C.     

Effects of lauryl sulphate on egg‐shell quality in laying hens

1. The effect of feeding the detergent, sodium lauryl sulphate at concentrations up to 10 g/kg diet on egg‐shell quality was examined in laying hens at 24, 36 and 48 weeks of age.

2. Lauryl sulphate at 2.5 g/kg or more in the diet significantly increased shell breaking strength, shell thickness and shell weight at 24 and 36 weeks. In 48‐week‐old hens only shell breaking strength was increased significantly. Egg production and egg weight were not affected significantly by lauryl sulphate.

3. Lauryl sulphate might increase these measures of quality by increasing shell deposition and/or shell elasticity.     

Cutaneous onchocerciasis in the horse: five cases in southwestern british columbia

Five horses were presented because of a dermatitis of the forehead. Unlike previous reports, ventral midline dermatitis was not the major problem, and was present in only two of five cases. All five horses responded to levamisole therapy at a daily dosage of 5.5 g for one week. Owners were cautioned that repeat therapy may be necessary.     

Diagnostic value of intestinal alkaline phosphatase in horse serum

Antiserum directed against equine intestinal Alkaline Phosphatase (ALP) was produced in rabbits and used to develop a sensitive and quantitative assay for the detection of intestinal ALP in equine serum. This assay was then used to measure the half-life of intravenously injected intestinal ALP and to determine if the intestinal ALP was present in normal horse sera, sera from horses presented for lesions not involving the gastrointestinal tract and sera from horses presented with lesions involving the gastrointestinal tract. The results suggest that intestinal ALP is not likely to appear in equine serum even when gastrointestinal disease is present and, therefore, appears to be of no diagnostic value.